Additionally, we report that inhibition of IL-1 signaling by administration of IL-1Ra markedly improves hepatic steatosis in DIO mice by significantly reducing hepatic inflammation and lipogenic gene expression. This evidence concerns the gene IL1A and fatty liver disease.